Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Bone Biologics Corporation announced a private placement of 2.1 million shares at $1.42 per share, raising $3.0 million upfront with potential additional $6.0 million from warrant exercises. The company plans to use proceeds for clinical trials, patent portfolio maintenance, and working capital. Closing expected July 9, 2026.